“The DOH, through its Advancing Health through Evidence-Assisted Decisions with Health Policy and System Research, has allocated P18 million for Avigan Trials,” the report said.
According to the report, there are already three sites identified for the trials. It, however, did not specify the locations.reportedly yielded positive results in treating COVID-19 patients in China, especially those with mild symptoms.
KAguilarINQ Mass testing dapat di yan.
KAguilarINQ Cloroquin and Hidroxicloroquin way cheaper and already being used around the world.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: